Can a daily routine fade melasma?
Part of Skin clinical trials.
This trial tests a daily routine of facial products to see if they can reduce dark patches (melasma) on your face. It is for people who have had melasma for at least a year and have not used certain creams like retinoids or hydroquinone recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had melasma on both sides of your face for more than a year.
- You have not used any prescription creams like tretinoin or hydroquinone for at least a few months (3 months for tretinoin, 6 months for hydroquinone).
- You are not pregnant or breastfeeding, and have not recently changed your birth control or hormone therapy.
- You do not have other skin problems on your face and are not taking medications that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
This trial tests if adding MelaB3 serum to a 35% glycolic acid peel works better than the peel alone for treating dark spots caused by melasma, acne scars, or sun damage. It may be a good option if you have mild to moderate dark spots and are willing to avoid sun exposure and other skin-lightening products.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.